Mr Mejlvang joined Novo Nordisk in 2002 and has since held more than 10 different positions across R&D, manufacturing and commercial operations. From 2004 to 2019, he served in various leadership roles across CMC & Product Supply, including assignments in France. In 2019, Mr Mejlvang transitioned to senior leadership roles in Global Operations, where he served as General Manager for Denmark & Iceland. In 2022, he was appointed General Manager and President of Novo Nordisk Pharma Ltd. in Japan.

Effective 1 January 2026, Mr Mejlvang was promoted Executive Vice President of CMC & Product Supply. In this role, he oversees approximately 30,000 employees and manages one of the largest CAPEX programmes in the pharmaceutical industry.

Currently none.

• 2002: MSc Management, University of Bath, UK.
• 2005: MSc in Psychology, University of Copenhagen, DK. 
• 2016: Executive MBA, IMD, CH.

Mr Mejlvang is a Danish national, born in 1977.